3-chloro-4-[(3-fluorophenyl)methoxy]aniline | CAS:202197-26-0

We serve 3-chloro-4-[(3-fluorophenyl)methoxy]aniline CAS:202197-26-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-chloro-4-[(3-fluorophenyl)methoxy]aniline

Chemical Name:3-chloro-4-[(3-fluorophenyl)methoxy]aniline
CAS.NO:202197-26-0
Synonyms:3-chloro-4-(3-fluoro-benzyloxy)-phenylamine
Molecular Formula:C13H11ClFNO
Molecular Weight:251.68400
 
Physical and Chemical Properties:
Density:1.306
Boiling point:387.9ºC
Flash point:188.4ºC
Index of Refraction:1.607
 
HS Code: 2922299090
 
Specification:
Appearance:Light pink or lavender powder
Purity:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lapatinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like 3-chloro-4-[(3-fluorophenyl)methoxy]aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-chloro-4-(3-fluoro-benzyloxy)-phenylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-chloro-4-[(3-fluorophenyl)methoxy]aniline Use and application,3-chloro-4-(3-fluoro-benzyloxy)-phenylamine technical grade,usp/ep/jp grade.


Related News: Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production.2-Amino-6-methylheptane hydrochloride manufacturer Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production.1-Bromo-8-iodonaphthalene supplier It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305.4-Difluoromethoxy-3-Hydroxybenzaldehyde vendor The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.